<- Go home

Added to YB: 2025-11-18

Pitch date: 2025-11-15

TWST [bullish]

Twist Bioscience Corporation

+15.67%

current return

Author Info

Clinical Catalysts breaks down the science and strategy behind pharma market movers. Sign up for the newsletter.

Company Info

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

Market Cap

$1.6B

Pitch Price

$26.74

Price Target

N/A

Dividend

N/A

EV/EBITDA

-16.66

P/E

-20.69

EV/Sales

3.93

Sector

Biotechnology

Category

growth

Show full summary:
Three Healthcare Names the Market is Sleeping On - Twist Bioscience Corporation

TWST: Synthetic biology leader w/ unique silicon-based DNA synthesis platform. Q3 +18% YOY rev to $96.1M, 53.4% gross margins, $20.4M net income. FY25 guidance $374-376M rev, expects EBITDA breakeven by end FY26. $250.8M cash, growing customer base to 2,484. Compelling pick-and-shovel play.

Read full article (2 min)